Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2013, Article ID 637181, 13 pages
http://dx.doi.org/10.1155/2013/637181
Research Article

Modeling of Non-Small Cell Lung Cancer Volume Changes during CT-Based Image Guided Radiotherapy: Patterns Observed and Clinical Implications

1Department of Radiation Oncology, Washington University School of Medicine, 4921 Parkview Place, Campus Box 8224, St. Louis, MO, 63110, USA
2Maine Medical Center, Southern Maine Radiation Therapy Institute, 22 Bramhall Street, Portland, ME 04102, USA
3Department of Radiation Oncology, Pocono Medical Center, 206 East Brown Street, East Stroudsburg, PA 18301, USA
4Nash Cancer Treatment Center, 2450 Curtis Ellis Drive, Rocky Mount, NC 27804, USA
5Department of Medical Oncology, The Brody School of Medicine, East Carolina University, 600 Moye Boulevard, Greenville, NC 27834, USA
621st Century Oncology, 801 W.H. Smith Boulevard, Greenville, NC 27834, USA
7Laboratory of Anticancer Pharmacology, Department of Oncology, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156 Milan, Italy

Received 7 March 2013; Revised 29 July 2013; Accepted 26 August 2013

Academic Editor: Thierry Busso

Copyright © 2013 Hiram A. Gay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Werner-Wasik, Y. Xiao, E. Pequignot, W. J. Curran, and W. Hauck, “Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study,” International Journal of Radiation Oncology Biology Physics, vol. 51, no. 1, pp. 56–61, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Bosmans, A. van Baardwijk, A. Dekker et al., “Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: a prospective clinical study,” International Journal of Radiation Oncology Biology Physics, vol. 66, no. 3, pp. 748–753, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Fox, E. Ford, K. Redmond, J. Zhou, J. Wong, and D. Y. Song, “Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer,” International Journal of Radiation Oncology Biology Physics, vol. 74, no. 2, pp. 341–348, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. A. Kupelian, C. Ramsey, S. L. Meeks et al., “Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment,” International Journal of Radiation Oncology Biology Physics, vol. 63, no. 4, pp. 1024–1028, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Zhang, O. Hyrien, K. J. Pandya, P. C. Keng, and Y. Chen, “Tumor response kinetics after schedule-dependent paclitaxel chemoradiation treatment for inoperable non-small cell lung cancer: a model for low-dose chemotherapy radiosensitization,” Journal of Thoracic Oncology, vol. 3, no. 6, pp. 563–568, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. R. M. Seibert, C. R. Ramsey, J. W. Hines et al., “A model for predicting lung cancer response to therapy,” International Journal of Radiation Oncology Biology Physics, vol. 67, no. 2, pp. 601–609, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. C. Erridge, Y. Seppenwoolde, S. H. Muller et al., “Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer,” Radiotherapy and Oncology, vol. 66, no. 1, pp. 75–85, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. R. W. M. Underberg, F. J. Lagerwaard, H. Van Tinteren, J. P. Cuijpers, B. J. Slotman, and S. Senan, “Time trends in target volumes for stage I non-small-cell lung cancer after stereotactic radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 64, no. 4, pp. 1221–1228, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. L. Siker, W. A. Tomé, and M. P. Mehta, “Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy: how reliable, consistent, and meaningful is the effect?” International Journal of Radiation Oncology Biology Physics, vol. 66, no. 1, pp. 135–141, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. C. G. Steel, “Cell population kinetics in relation to the growth and treatment of cancer,” in Growth Kinetics of Tumors, Clarendon Press, Oxford, UK, 1977. View at Google Scholar
  11. O. Arino, “A survey of structured cell population dynamics,” Acta Biotheoretica, vol. 43, no. 1-2, pp. 3–25, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Basse and P. Ubezio, “A generalised age- and phase-structured model of human tumour cell populations both unperturbed and exposed to a range of cancer therapies,” Bulletin of Mathematical Biology, vol. 69, no. 5, pp. 1673–1690, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Spinelli, A. Torricelli, P. Ubezio, and B. Basse, “Modelling the balance between quiescence and cell death in normal and tumour cell populations,” Mathematical Biosciences, vol. 202, no. 2, pp. 349–370, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. G. F. Webb, Theory of Nonlinear Age-Dependent Population Dynamics, Dekker, New York, NY, USA, 1985.
  15. A. Bertuzzi, A. Gandolfi, C. Sinisgalli, and D. Iacoviello, “Steel's potential doubling time and its estimation in cell populations affected by nonuniform cell loss,” Mathematical Biosciences, vol. 143, no. 2, pp. 61–89, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Ubezio and D. Cameron, “Cell killing and resistance in pre-operative breast cancer chemotherapy,” BMC Cancer, vol. 8, article 201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. B. C. Baguley and E. S. Marshall, “In vitro modelling of human tumour behaviour in drug discovery programmes,” European Journal of Cancer, vol. 40, no. 6, pp. 794–801, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. D. A. Rew and G. D. Wilson, “Cell production rates in human tissues and tumours and their significance. Part 1: an introduction to the techniques of measurement and their limitations,” European Journal of Surgical Oncology, vol. 26, no. 3, pp. 227–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. J. S. Spratt, J. S. Meyer, and J. A. Spratt, “Rates of growth of human neoplasms, Part II,” Journal of Surgical Oncology, vol. 61, no. 1, pp. 68–83, 1996. View at Google Scholar
  20. G. G. Steel, Basic Clinical Radiobiology, Arnold, London, UK, 2002.
  21. L. M. M. F. Demarchi, M. M. Reis, S. A. P. Palomino et al., “Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung,” Modern Pathology, vol. 13, no. 5, pp. 511–520, 2000. View at Google Scholar · View at Scopus
  22. H. Ishida, K. Irie, T. Itoh, T. Furukawa, and O. Tokunaga, “The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction,” Cancer, vol. 80, no. 6, pp. 1034–1045, 1997. View at Google Scholar
  23. M. M. F. J. Tinnemans, B. Schutte, M. H. J. H. Lenders, G. P. M. Ten Velde, F. C. S. Ramaekers, and G. H. Blijham, “Cytokinetic analysis of lung cancer by in vivo bromodeoxyuridine labelling,” British Journal of Cancer, vol. 67, no. 6, pp. 1217–1222, 1993. View at Google Scholar · View at Scopus
  24. M. Aitkin, D. Anderson, B. Freancis, and J. Hinde, Statistical Modelling in GLIM, Oxford Science Publications, 1989.
  25. K. R. Britton, G. Starkschall, S. L. Tucker et al., “Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 4, pp. 1036–1046, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Ribba, G. Kaloshi, M. Peyre et al., “A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy,” Clinical Cancer Research, vol. 18, pp. 5071–5080, 2012. View at Publisher · View at Google Scholar
  27. G. D. Wilson, “Radiation and the cell cycle, revisited,” Cancer and Metastasis Reviews, vol. 23, no. 3-4, pp. 209–225, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Simeoni, P. Magni, C. Cammia et al., “Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents,” Cancer Research, vol. 64, no. 3, pp. 1094–1101, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Sorace and N. L. Komarova, “Accumulation of neutral mutations in growing cell colonies with competition,” Journal of Theoretical Biology, vol. 314, pp. 84–94, 2012. View at Google Scholar
  30. J. Foo and F. Michor, “Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies,” PLoS Computational Biology, vol. 5, no. 11, Article ID e1000557, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. N. L. Komarova and D. Wodarz, “Drug resistance in cancer: principles of emergence and prevention,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 27, pp. 9714–9719, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Michor, T. P. Hughes, Y. Iwasa et al., “Dynamics of chronic myeloid leukaemia,” Nature, vol. 435, no. 7046, pp. 1267–1270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Budach, V. Budach, M. E. Scheulen, M. Stuschke, and P. Chaborski, “Drug- and radiation-induced resistance in a human neurogenic sarcoma xenografted in nude mice,” Cancer Chemotherapy and Pharmacology, vol. 31, supplement 2, pp. S169–S173, 1993. View at Google Scholar · View at Scopus
  34. S. Masunaga, K. Ono, H. Hori et al., “Change in oxygenation status in intratumour total and quiescent cells following γ-ray irradiation, tirapazamine administration, cisplatin injection and bleomycin treatment,” British Journal of Radiology, vol. 73, no. 873, pp. 978–986, 2000. View at Google Scholar · View at Scopus
  35. T. Nakano and K. Oka, “Transition of Ki-67 index of uterine cervical tumors during radiation therapy: immunohistochemical study,” Cancer, vol. 68, no. 3, pp. 517–523, 1991. View at Google Scholar · View at Scopus
  36. A. Bertuzzi, A. Fasano, A. Gandolfi, and C. Sinisgalli, “Cell resensitization after delivery of a cycle-specific anticancer drug and effect of dose splitting: learning from tumour cords,” Journal of Theoretical Biology, vol. 244, no. 3, pp. 388–399, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. E. J. Hall and A. J. Giaccia, Radiobiology For the Radiologist, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 6th edition, 2006.
  38. E. Quaia, E. Baratella, R. Pizzolato, R. Bussani, and M. A. Cova, “Radiological-pathological correlation in intratumoural tissue components of solid lung tumours,” Radiologia Medica, vol. 114, no. 2, pp. 173–189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Takeda, N. Sanuki, E. Kunieda et al., “Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm,” International Journal of Radiation Oncology Biology Physics, vol. 73, no. 2, pp. 442–448, 2009. View at Publisher · View at Google Scholar · View at Scopus